SCHEMBL6673967

SCHEMBL6673967

CC(c1ccccc1)[C@@](C)(C(=O)O)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ AOC3 Q16853 2/20 0.41
▸ ATM Q13315 2/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6672417 0.86 ESR1 (0.41) ALDH1A1GAACYP2D6CYP1A2SRC
SCHEMBL28569677 0.83 KCNN4 (0.43) KDM4EATMMTORL3MBTL1SRC
SCHEMBL7277613 0.78 MEN1 (0.40) KDM4EALDH1A1
SCHEMBL8053595 0.76 CYP2D6 (0.43) ATMALOX5CYP2D6CYP1A2L3MBTL1
SCHEMBL173884 0.76 L3MBTL1 (0.43) AOC3ATMALOX5CYP2D6CYP1A2
SCHEMBL60355 0.75 KMT2A (0.42) ATMALOX5CYP2D6CYP1A2L3MBTL1
SCHEMBL11159095 0.74 AOC3 (0.44) KDM4EAOC3ATMALOX5ALDH1A1
SCHEMBL23357274 0.74 CYP2D6 (0.44) ALOX5ALDH1A1CYP2D6CYP1A2SRC
SCHEMBL17242271 0.74 CYP2D6 (0.44) ALOX5ALDH1A1CYP2D6CYP1A2SRC
SCHEMBL17242270 0.74 CYP2D6 (0.44) ALOX5ALDH1A1CYP2D6CYP1A2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026293-A2 HEMIASTERLIN DERIVATIVES FOR TREATING RESISTANT TUMORS WYETH HOLDINGS CORPORATION (US) 2004-04-01 — — WO disclosed
Send feedback